Healthcare Facilities company Rainbow Childrens Medicare announced Q4FY25 & FY25 results Q4FY25 Financial Highlights: Revenue rose by 8.5% to Rs 3,701.1 million from Rs 3,411.0 million. EBITDA increased by 8.7% to Rs 1,147.3 million from Rs 1,055.4 million. EBITDA Margin improved by 6 bps to 31.0% from 30.9%. PAT grew by 10.7% to Rs 565.5 million from Rs 510.7 million. PAT Margin expanded by 31 bps to 15.3% from 15.0%. FY25 Financial Highlights: Revenue grew by 16.9% to Rs 15,158.7 million from Rs 12,969.0 million. EBITDA rose by 14.2% to Rs 4,898.9 million from Rs 4,288.8 million. EBITDA Margin declined by 75 bps to 32.3% from 33.1%. PAT increased by 11.9% to Rs 2,442.3 million from Rs 2,182.9 million. PAT Margin contracted by 72 bps to 16.1% from 16.8%. Speaking about the performance for Q4FY25, Ramesh Kancharla, Chairman & Managing Director of Rainbow Children’s Medicare , said: “On the operational front, our performance in Q4 is seasonally muted when compared to the stronger results delivered in the second and third quarters of the year. In Q4FY25, our revenue stood at Rs 3,701.1 million, reflecting a year-on-year increase of 8.5% from Rs 3,411 million in Q4FY24. Our EBITDA reached Rs 1,147.3 million, up 8.7% from Rs 1,055.4 million, while our PAT rose 10.7% to Rs 565.5 million from Rs 510.7 million in the same period last year. With a network of over 2,000 beds, including managed facilities, we have a well-balanced mix of established and emerging hospitals. Our immediate focus remains on improving occupancy levels, streamlining operations, and upholding our commitment to exceptional patient care. With this strong foundation in place, I remain confident in our continued growth and success in the quarters ahead” Result PDF
Conference Call with Rainbow Childrens Medicare Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.